Anthera Pharmaceuticals, Inc. (ANTH)
OTCMKTS: ANTH · Delayed Price · USD
0.0000
-0.0001 (-99.00%)
Jan 2, 2024, 3:32 PM EDT - Market closed

Anthera Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2022202120202019201720162015201420132012 2011 - 2005
Revenue
000000.153.19000
Upgrade
Revenue Growth (YoY)
------95.45%----
Upgrade
Gross Profit
000000.153.19000
Upgrade
Selling, General & Admin
00007.9411.077.576.626.566.72
Upgrade
Research & Development
000028.5946.2530.8621.8421.6849.22
Upgrade
Other Operating Expenses
0000-0.0900000
Upgrade
Operating Expenses
000036.5357.3238.4328.4628.2555.93
Upgrade
Operating Income
0000-36.43-57.18-35.24-28.46-28.25-55.93
Upgrade
Interest Expense
00000001.052.63.35
Upgrade
Other Expense / Income
-----9.56-1.65-0.020.10.02-2.91
Upgrade
Pretax Income
0000-26.87-55.52-35.22-29.6-30.86-59.4
Upgrade
Income Tax
0000-9.94-1.92-0.310.712.253.02
Upgrade
Net Income
0000-16.94-53.6-34.91-30.31-33.11-59.4
Upgrade
Shares Outstanding (Basic)
----1054321
Upgrade
Shares Outstanding (Diluted)
----1054321
Upgrade
Shares Change
----99.05%15.94%63.62%19.21%152.82%54.48%
Upgrade
EPS (Basic)
-----1.65-10.38-7.84-11.13-14.50-65.77
Upgrade
EPS (Diluted)
-----1.65-10.38-7.84-11.13-14.50-65.77
Upgrade
Free Cash Flow
0000-36.9-49.69-30.99-25.6-31.93-73.84
Upgrade
Free Cash Flow Per Share
-----3.59-9.62-6.96-9.41-13.98-81.76
Upgrade
Gross Margin
-----100.00%100.00%---
Upgrade
Operating Margin
------39432.41%-1106.53%---
Upgrade
Profit Margin
------36967.59%-1096.14%---
Upgrade
Free Cash Flow Margin
------34265.52%-972.90%---
Upgrade
EBITDA
0000-46.19-58.83-35.27-28.46-28.25-55.93
Upgrade
EBITDA Margin
------40573.10%-1107.25%---
Upgrade
Depreciation & Amortization
00000.280.270.290.340.350.33
Upgrade
EBIT
-----46.47-59.1-35.55-28.8-28.6-56.27
Upgrade
EBIT Margin
------40756.55%-1116.20%---
Upgrade
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.